Issue 2/2008
Content (25 Articles)
Further mechanistic unravelling of the influence of the cell cycle effects on the radiosensitising mechanism of vinflunine, in vitro
Cindy Simoens, Bea Pauwels, Jan B. Vermorken, Greet G. O. Pattyn, Hilde A. J. Lambrechts, Fabienne Breillout, Filip Lardon
Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases
M. Ychou, F. Viret, A. Kramar, F. Desseigne, E. Mitry, R. Guimbaud, J. R. Delpero, M. Rivoire, F. Quénet, G. Portier, B. Nordlinger
The relative bioavailability of gefitinib administered by granular formulation
Mireille V. Cantarini, Chris J. Bailey, Barbara Collins, Robert P. Smith
Phase II study of rubitecan in recurrent or metastatic head and neck cancer
Francesco Caponigro, Giacomo Cartenì, Jean Pierre Droz, Amalia Milano, Wayne B. Davis, Patricia Pollard
The depletion of cellular ATP by AG2034 mediates cell death or cytostasis in a hypoxanthine-dependent manner in human prostate cancer cells
Oluwakemi Obajimi, Peter W. Melera
Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial
H. Ian Robins, Anne O’Neill, Mark Gilbert, Mark Olsen, Ronald Sapiente, Brian Berkey, Minesh Mehta
Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models
D. Thomas Dickey, Leslie L. Muldoon, Nancy D. Doolittle, Darryl R. Peterson, Dale F. Kraemer, Edward A. Neuwelt
A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers
Wei-Peng Yong, Ling-Zhi Wang, Lai-San Tham, Chiung-Ing Wong, Soo-Chin Lee, Ross Soo, Norita Sukri, How-Sung Lee, Boon-Cher Goh
Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC)
Fernando Rivera, M. Eugenia Vega-Villegas, Marta López-Brea, Dolores Isla, Marta Mayorga, Piedad Galdós, Antonio Rubio, Adolfo Del Valle, Fe García-Reija, Belen García-Montesinos, Julio Rodríguez-Iglesias, Jose Mayordomo, Julio Rama, Ramón Saiz-Bustillo, Jaime Sanz-Ortiz
Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study
Yeul Hong Kim, Hyun Cheol Chung, Won Ki Kang, Sook Ryun Park, Chul Soo Kim, Tae-Yue Kim, Sang Won Shin, Byung-Joo Park, Soo Jin Cha, Yung-Jue Bang
Changes of cytokines in cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy
Hidenari Nagai, Daisuke Miyaki, Teppei Matsui, Masahiro Kanayama, Katsuya Higami, Kouichi Momiyama, Takashi Ikehara, Manabu Watanabe, Yasukiyo Sumino, Kazumasa Miki
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study
E. Briasoulis, G. Fountzilas, A. Bamias, M. A. Dimopoulos, N. Xiros, G. Aravantinos, E. Samantas, H. Kalofonos, T. Makatsoris, N. Mylonakis, P. Papakostas, D. Skarlos, I. Varthalitis, N. Pavlidis
Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women ≥65 years of age
Raffaele Addeo, Vincenzo Faiola, Rosario Guarrasi, Liliana Montella, Bruno Vincenzi, Elena Capasso, Gregorio Cennamo, Maria Saveria Rotundo, Pierosandro Tagliaferri, Michele Caraglia, Salvatore Del Prete
Temozolomide in combination with fotemustine in patients with metastatic melanoma
Faruk Tas, Hakan Camlica, Erkan Topuz
Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP
Hye Jin Kang, Won Seog Kim, Cheolwon Suh, Yeon Hee Park, Bong Seog Kim, Young Jin Yuh, Baek-Yeol Ryoo
Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines
Nasredine Aissat, Christophe Le Tourneau, Aïda Ghoul, Maria Serova, Ivan Bieche, François Lokiec, Eric Raymond, Sandrine Faivre
Extracellular signal-regulated kinase phosphorylation due to menadione-induced arylation mediates growth inhibition of pancreas cancer cells
Shinji Osada, Fumio Sakashita, Yosiki Hosono, Kenichi Nonaka, Yasuharu Tokuyama, Hidenori Tanaka, Yoshiyuki Sasaki, Hiroyuki Tomita, Shuji Komori, Satoshi Matsui, Takao Takahashi
Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs
Michael Fiegl, Lars H. Lindner, Matthias Juergens, Hansjoerg Eibl, Wolfgang Hiddemann, Jan Braess
Syndrome of inappropriate secretion of antidiuretic hormone after chemotherapy with vinorelbine
Hiroaki Kuroda, Masafumi Kawamura, Tai Hato, Kazunori Kamiya, Masahiro Kawakubo, Yotaro Izumi, Masazumi Watanabe, Hirohisa Horinouchi, Koichi Kobayashi
Syndrome of inappropriate secretion of antidiuretic hormone after chemotherapy with vinorelbine
Hiroaki Kuroda, Masafumi Kawamura, Tai Hato, Kazunori Kamiya, Masahiro Kawakubo, Yotaro Izumi, Masazumi Watanabe, Hirohisa Horinouchi, Koichi Kobayashi, Mitsuo Nakayama
Mechanisms of enhanced tumoricidal efficacy of multiple small dosages of ranpirnase, the novel cytotoxic ribonuclease, on lung cancer
Intae Lee, Kuslima Shogen
Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinoma
Saby George, Thomas E. Hutson, Tarek Mekhail, Laura Wood, James Finke, Paul Elson, Robert Dreicer, Ronald M. Bukowski
Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis
Ronald J. Bernardi, Lisa Bomgaars, Elizabeth Fox, Frank M. Balis, Merrill J. Egorin, Theodore F. Lagattuta, Alberta Aikin, Patricia Whitcomb, Jamie Renbarger, Frank S. Lieberman, Stacey L. Berg, Susan M. Blaney
Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU)
Jan H. Beumer, Robert A. Parise, Edward M. Newman, James H. Doroshow, Timothy W. Synold, Heinz-Josef Lenz, Merrill J. Egorin
Consumption of silibinin, a flavonolignan from milk thistle, and mammary cancer development in the C3(1) SV40 T,t antigen transgenic multiple mammary adenocarcinoma (TAg) mouse
Richard D. Verschoyle, Karen Brown, William P. Steward, Andreas J. Gescher